NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3024% below fair value
$14.82−0.27 (-1.79%)
Close on Nov 20, 2026Market cap $1.92BP/E –Yield –
NeoGenomics net income
Net income is the profit left for shareholders after every expense, interest and tax.
NeoGenomics's net income for the twelve months ending Sep 30, 2026 was -$32.30M. For fiscal 2025 it was -$108.03M. The highest annual figure on record is $8.01M in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$108.03M | – |
| FY2024 | Dec 31, 2024 | -$78.73M | – |
| FY2023 | Dec 31, 2023 | -$87.97M | – |
| FY2022 | Dec 31, 2022 | -$144.25M | – |
| FY2021 | Dec 31, 2021 | -$8.35M | -300.1% |
| FY2020 | Dec 31, 2020 | $4.17M | -47.9% |
| FY2019 | Dec 31, 2019 | $8.01M | +203.3% |
| FY2018 | Dec 31, 2018 | $2.64M | – |
| FY2017 | Dec 31, 2017 | -$396.00K | – |
| FY2016 | Dec 31, 2016 | -$6.14M | – |
| FY2015 | Dec 31, 2015 | -$2.54M | -323.9% |
| FY2014 | Dec 31, 2014 | $1.13M | -44.3% |
| FY2013 | Dec 31, 2013 | $2.03M | +3027.7% |
| FY2012 | Dec 31, 2012 | $65.00K | – |
| FY2011 | Dec 31, 2011 | -$1.18M | – |
| FY2010 | Dec 31, 2010 | -$3.30M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$7.55M | – |
| Q2 FY2026 | Jun 30, 2026 | $2.24M | – |
| Q1 FY2026 | Mar 31, 2026 | -$17.11M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.88M | – |
| Q3 FY2025 | Sep 30, 2025 | -$27.13M | – |
| Q2 FY2025 | Jun 30, 2025 | -$45.09M | – |
| Q1 FY2025 | Mar 31, 2025 | -$25.92M | – |
| Q4 FY2024 | Dec 31, 2024 | -$15.32M | – |
| Q3 FY2024 | Sep 30, 2024 | -$17.70M | – |
| Q2 FY2024 | Jun 30, 2024 | -$18.64M | – |
| Q1 FY2024 | Mar 31, 2024 | -$27.06M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.33M | – |
| Q3 FY2023 | Sep 30, 2023 | -$18.52M | – |
| Q2 FY2023 | Jun 30, 2023 | -$24.33M | – |
| Q1 FY2023 | Mar 31, 2023 | -$30.80M | – |
| Q4 FY2022 | Dec 31, 2022 | -$22.69M | – |
| Q3 FY2022 | Sep 30, 2022 | -$36.85M | – |
| Q2 FY2022 | Jun 30, 2022 | -$35.30M | -146.5% |
| Q1 FY2022 | Mar 31, 2022 | -$49.41M | – |
| Q4 FY2021 | Dec 31, 2021 | -$41.76M | -370.9% |
| Q3 FY2021 | Sep 30, 2021 | -$20.35M | -895.8% |
| Q2 FY2021 | Jun 30, 2021 | $75.87M | – |
| Q1 FY2021 | Mar 31, 2021 | -$22.11M | – |
| Q4 FY2020 | Dec 31, 2020 | $15.42M | +144.9% |
| Q3 FY2020 | Sep 30, 2020 | $2.56M | +19.3% |
| Q2 FY2020 | Jun 30, 2020 | -$6.82M | -442.7% |
| Q1 FY2020 | Mar 31, 2020 | -$6.98M | – |
| Q4 FY2019 | Dec 31, 2019 | $6.30M | +1683.6% |
| Q3 FY2019 | Sep 30, 2019 | $2.14M | +5.9% |
| Q2 FY2019 | Jun 30, 2019 | $1.99M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.42M | -476.4% |
| Q4 FY2018 | Dec 31, 2018 | $353.00K | -92.2% |
| Q3 FY2018 | Sep 30, 2018 | $2.02M | – |
| Q2 FY2018 | Jun 30, 2018 | -$380.00K | -178.7% |
| Q1 FY2018 | Mar 31, 2018 | $644.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $4.55M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.26M | – |
| Q2 FY2017 | Jun 30, 2017 | $483.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.17M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.22M | – |
See a number that looks wrong?